Fri.Feb 28, 2025

article thumbnail

2025 STAT Madness

STAT

2025 bracket Welcome to STAT Madness, a bracket-style contest to find the best innovation in science and medicine. Explore groundbreaking innovations from top institutions and help crown the 2025 STAT Madness champion. Your vote determines who advances in this competition celebrating the best in biomedical research.

363
363
article thumbnail

Teva targets schizophrenia to build on innovative medicines growth

PharmaVoice

The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.

147
147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NIH cancels summer internship program

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. It’s almost March! Which means voting for our annual STAT Madness competition starts Monday. I will see you in the brackets.

204
204
article thumbnail

Preparing for a new era in the rare disease sector

European Pharmaceutical Review

Rare disease research has surged over the past decade. When observing literature trends over the past twenty years, the amount of rare disease literature being published each year has more than tripled ( Figure 1 ). 1 Following the current trend, there has been a significant rise in the number of documents mentioning both artificial intelligence (AI) and rare diseases.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Inborn errors of metabolism elicit unique challenges for therapy development

Pharmaceutical Technology

As Rare Disease Day is commemorated on 28 February, experts discuss the barriers to gene therapy access for some rare diseases.

104
104
article thumbnail

Leqembi, after delay, gets back on track toward EU approval

BioPharma Dive

European regulators “reaffirmed” a positive view of Eisai and Biogen’s Alzheimer’s drug after conducting a new safety review.

96

More Trending

article thumbnail

Express Pharma March 2025

Express Pharma

The Leadership Playbook: Tech, Talent, Transformation Click to download: March 2025 Digital Magazine The post Express Pharma March 2025 appeared first on Express Pharma.

69
article thumbnail

BridgeBio oncology spinout to go public in blank-check merger

BioPharma Dive

The deal comes amid an uptick in so-called SPAC deals, which had fallen out of favor due to poor returns and increased federal oversight.

67
article thumbnail

Owkin launches ATLANTIS patient data mining project

pharmaphorum

Owkin has partnered 20 healthcare institutions on a patient data mining project, ATLANTIS, across oncology, immunology/inflammation, and neurology

66
article thumbnail

Rare disease treatments skipping UK patients largely due to costs, survey shows

Pharmaceutical Technology

A survey has shown that pharma companies have low confidence their rare disease medicines can launch in the UK.

64
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Switching between defense and attack - immune cells with dual role

World Pharma News

LMU researchers have shown that a particular type of immune cell acts more flexibly than previously thought - with potential for new therapeutic approaches. As part of the innate immune system, dendritic cells are in the body's first line of defense against infections. They detect pathogens and coordinate the immune response.

article thumbnail

FDA clears lifesaving feature for Google's Pixel Watch 3

pharmaphorum

The FDA has approved loss of pulse detection for Google's Pixel Watch 3, almost six months after the smartwatch was launched in the US.

59
article thumbnail

Rare Disease Day 2025: Pharmaceutical Treatments Advancing in the US, EU

PharmaTech

Regulatory clearances and approvals continue as agencies work to disseminate literature, raise awareness, redouble research efforts, and improve the efficacy of clinical trials.

59
article thumbnail

AbbVie closes on Rinvoq approval in inflamed artery disease

pharmaphorum

AbbVie's Rinvoq is poised to become the first oral targeted treatment for giant cell arteritis in the EU after being backed by the CHMP

59
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

CHMP recommends AbbVie’s Rinvoq be approved for adult GCA

Pharmaceutical Technology

The CHMP has recommended the approval of AbbVie's upadacitinib (Rinvoq) for treating adults with giant cell arteritis (GCA).

59
article thumbnail

Praxis hits trial setback; Bristol Myers lays off staff in New Jersey

BioPharma Dive

The brain drug developer is continuing a trial despite a recommendation it be stopped for futility. Elsewhere, Eli Lilly struck a molecular glue deal and Zevra sold a priority review voucher.

article thumbnail

Why pharma is still far from a treatment for galactosemia

Pharmaceutical Technology

With issues in therapy delivery and a barren trial landscape, short-term chances for a commercial galactosemia treatment are low.

59
article thumbnail

EMA Recommends Four Medicines for Approval in February

PharmaTech

Treatments for autoimmune diseases, multiple cancers, and skin blistering have been recommended for marketing approval.

52
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Medigene and EpimAb to develop T cell engagers for solid tumours

Pharmaceutical Technology

Medigene and EpimAb Biotherapeutics have signed a co-development agreement involving T cell receptor (TCR)-guided T cell engagers (TCR-TCEs).

59
article thumbnail

FDA Expands Odactra Label to Include Children Aged 5-11 for Dust Mite-Induced Allergic Rhinitis

PharmExec

Results from a Phase III study in pediatric patients demonstrated that Odactra reduced the total combined rhinitis score by 22% compared to placebo.

article thumbnail

Exelixis focuses on future growth despite COSMIC-313 trial challenges

Pharmaceutical Technology

At the American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposium 2025, held on 13-15 February, final results from the randomised, multicentre, double-blind, Phase III COSMIC-313 clinical trial were presented.

59
article thumbnail

FDA Approves Investigational New Drug Application for Fapon Biopharma’s Novel Immunotherapy for Solid Tumors

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

FDA accepts Sobi’s Gamifant application for HLH/MAS treatment

Pharmaceutical Technology

The FDA has accepted Sobis sBLA for Gamifant for haemophagocytic lymphohistiocytosis (HLH)/MAS associated with Stills disease.

59
article thumbnail

Why it is more important than ever to optimise and innovate rare disease research

pharmaphorum

Find out why optimising and innovating rare disease research is crucial in today's world. Learn about the significance of research and its impact on individuals with rare diseases.

52
article thumbnail

Selecting the Right 3PL

Pharmaceutical Commerce

Tracy Lopez uncovers the fundamentals pertaining to third-party logistics providers.

52
article thumbnail

On incentivisation and investment in rare disease R&D

pharmaphorum

Discover the importance of incentivisation and increased investment in research and development for rare diseases. Learn how these initiatives can drive progress in finding treatments and cures for those in need.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Will Tariffs Affect Branded Drug Prices?

Pharmaceutical Commerce

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics at USC, describes how the tariffs can affect price or competition within the branded drug space.

article thumbnail

Patient-focused manufacturing models for personalised therapies

pharmaphorum

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Jason Bock, co-founder and CEO of CTMC, a first-of-its-kind cell therapy engine aiming to advance novel scientific breakthroughs into medicines developed rapidly and robustly to - ultimately - end cancer.

52
article thumbnail

2025 Pharma Forecast: Four Pivotal Trends Revolutionizing Market Access Strategies

Pharmaceutical Commerce

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

52
article thumbnail

Enhanced Intellectual Property Protection: Q&A with Lauren D’Angelo

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.